Promethazine Hydrochloride Tablet
FDA Label NDC 0904-7304

11 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Promethazine Hydrochloride (NDC 0904-7304). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, precautions, adverse reactions, overdosage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-7304-61

Unit Dose

Promethazine

Hydrochloride

Tablets, USP

25 mg

100 TABLETS (10 x 10)

Rx only

25mg Carton Label (Eb9e03f5 1fa6 4b8a 9066 Dc8bcbe9f476 00)

25mg Carton Label (Eb9e03f5 1fa6 4b8a 9066 Dc8bcbe9f476 00)

* Please review the disclaimer below.